FITC anti-human PD-1 (CD279, PD1) antibody: Fluorescein conjugate

Contents: Fluorescein isothiocyanate (FITC) anti-human PD-1 (CD279, PD1)
Catalog Number: 11-9969
Formulation: Phosphate buffered saline, pH 7.2, less than or equal to 0.09% NaN₃, BSA and/or gelatin for protein stabilization
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
LIGHT-SENSITIVE MATERIAL.
Clone: MIH4
Isotype: Mouse IgG1, κ

Prices for This Product*
Cat. No.	Size	Price	Qty	Action
11-9969-71	25 tests	$140
11-9969-73	100 tests	$275

*International customers: Please contact your distributor for region specific pricing.

Staining of 3-day PHA-activated normal human peripheral blood mononuclear cells with FITC Mouse IgG1, K Iso Cntrl (cat. 11-4714) (open histogram) or FITC anti-human PD-1 (MIH4) (colored histogram). Total viable cells were used for analysis.

Available Formats of This Product
Cat. No.	Format	Excite (nm)	Emit (nm)	Reported Applications
11-9969	Fluorescein isothiocyanate (FITC) anti-human PD-1 (CD279, PD1)	488	518	FC
12-9969	Phycoerythrin (PE) anti-human PD-1 (CD279, PD1)	488	575	FC
17-9969	Allophycocyanin (APC) anti-human PD-1 (CD279, PD1)	633	660	FC
51-9969	Alexa Fluor® 647 anti-human PD-1 (CD279, PD1)	633	668	FC
14-9969	Affinity Purified anti-human PD-1 (CD279, PD1)	N/A	N/A	FC IH/F

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.

Description

The MIH4 monoclonal antibody reacts with the human PD-1 (programmed death-1), a 55 kDa member of the immunoglobulin superfamily. PD-1 contains the immunoreceptor tyrosine-based inhibitory motif (ITIM) and plays a key role in peripheral tolerance and autoimmune disease. PD-1 is expressed predominantly on activated T and B lymphocytes. Two novel members of the B7 family have been identified as the PD-1 ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC). Evidence reported to date suggests overlapping functions for these two PD-1 ligands and their constitutive expression on some normal tissues and upregulation on activated antigen-presenting cells.

Applications Reported

For research use only, not for diagnostic or therapeutic use. This MIH4 antibody has been reported for use in flow cytometric analysis.

Applications Tested

This MIH4 antibody has been pre-titrated and tested by flow cytometric analysis of PHA-stimulated normal human peripheral blood mononuclear cells. This can be used at 20 μl (2.0 μg) per 100 μl blood (or per 1 million cells in 100 μl total staining volume).

References

Zhang JY, Zhang Z, Wang X, Fu JL, Yao J, Jiao Y, Chen L, Zhang H, Wei J, Jin L, Shi M, Gao GF, Wu H, Wang FS. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors.Blood. 2007 Jun 1;109(11):4671-8. (MIH4, FC, PubMed)

Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res. 2007 Mar 15;13(6):1757-61. (MIH4, IHC frozen)

Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, Fukushima T, Akiba H, Yagita H, Okumura K, Machida U, Iwai H, Azuma M, Chen L, Watanabe M. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol. 2003 Oct 15;171(8):4156-63. (MIH4, IHC frozen)

Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, Saura R,Kurosaka M, Honjo T, Kumagai S. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol. 2003 Jul;30(7):1410-9.

Iwai Y, Okazaki T, Nishimura H, Kawasaki A, Yagita H, Honjo T. Microanatomical localization of PD-1 in human tonsils. Immunol Lett. 2002 Oct 1;83(3):215-20.

Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. PD-L2 is a second ligand for PD-I and inhibits T cell activation. Nat Immunol. 2001 Mar;2(3):261-8.

Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000 Oct 2;192(7):1027-34.

Nishimura, H., Y. Agata, et al. (1996). Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol 8(5): 773-80.

Agata, Y., A. Kawasaki, et al. (1996). Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8(5): 765-72.

Related Products

Cat. 11-4714    Fluorescein isothiocyanate (FITC) Mouse IgG1, K Isotype Control
Cat. 14-9989    Affinity Purified anti-human PD-1 (CD279, PD1) (clone J116)
Cat. 16-9989    Functional Grade Purified anti-human PD-1 (CD279, PD1) (clone J116)